Literature DB >> 7544155

Expression of the proto-oncogene rhombotin-2 is identical to the acute phase response protein metallothionein, suggesting multiple functions.

G A Neale1, S Mao, D M Parham, K G Murti, R M Goorha.   

Abstract

Rhombotin-2 (RBTN-2) is a LIM domain protein that, with the exception of thymocytes, is widely expressed during fetal development. Although RBTN-2 is crucial for normal erythropoiesis, the ectopic expression of RBTN-2 in T lymphocytes results in T-cell proliferation and leukemogenesis. Thus, while a proliferative function for RBTN-2 has been established in T-cells, neither its role in erythropoiesis nor its function(s) in other tissues are known. We have examined the expression and location of RBTN-2 in normal and malignant cells. Similar to fetal development, RBTN-2 RNA was detected in all normal adult tissues tested with the exception of colon and thymocytes. RBTN-2 RNA was not detected in all primary tumors and tumor cell lines, indicating RBTN-2 expression is not ubiquitous in proliferating cells. Using polyclonal antisera, RBTN-2 was detected predominantly in the nucleus of human hematopoietic cells. Significantly, human leukemic T cells with disruption of the RBTN-2 locus and thymocytes from transgenic mice with enforced expression of RBTN-2 showed similar nuclear location of RBTN-2 protein, consistent with the notion that RBTN-2 acts as a transcriptional regulator in T-cell proliferation. Surprisingly, in normal tissues, RBTN-2 showed a strikingly similar distribution to that of metallothionein-1, having both nuclear and cytoplasmic localization that suggested that RBTN-2 may be involved in the acute phase response. Indeed, similar to metallothionein-1, RBTN-2 mRNA was induced in thymocytes of mice exposed to zinc and in human thymocytes treated with the phorbol ester 12-O-tetradecanoylphorbol-13-acetate. Since the LIM domain permits binding of multiple protein partners, the specific function of RBTN-2 may depend upon subcellular sequestration through interaction with different cofactors. Thus, in addition to its roles in erythropoiesis and T-cell leukemia, RBTN-2 may also be involved in the acute phase response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544155

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  5 in total

1.  LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL.

Authors:  Salma Parvin; Ariel Ramirez-Labrada; Shlomzion Aumann; XiaoQing Lu; Natalia Weich; Gabriel Santiago; Elena M Cortizas; Eden Sharabi; Yu Zhang; Isidro Sanchez-Garcia; Andrew J Gentles; Evan Roberts; Daniel Bilbao-Cortes; Francisco Vega; Jennifer R Chapman; Ramiro E Verdun; Izidore S Lossos
Journal:  Cancer Cell       Date:  2019-08-22       Impact factor: 31.743

2.  Identification and characterization of LMO4, an LMO gene with a novel pattern of expression during embryogenesis.

Authors:  D A Kenny; L W Jurata; Y Saga; G N Gill
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

3.  LMO2 expression is frequent in T-lymphoblastic leukemia and correlates with survival, regardless of T-cell stage.

Authors:  Kerri-Ann Latchmansingh; Xiaoqiong Wang; Ramiro E Verdun; Mario L Marques-Piubelli; Francisco Vega; M James You; Jennifer Chapman; Izidore S Lossos
Journal:  Mod Pathol       Date:  2022-03-23       Impact factor: 8.209

Review 4.  LMO2 at 25 years: a paradigm of chromosomal translocation proteins.

Authors:  Jennifer Chambers; Terence H Rabbitts
Journal:  Open Biol       Date:  2015-06       Impact factor: 6.411

Review 5.  Hematopoietic Stem Cell Transcription Factors in Cardiovascular Pathology.

Authors:  Sushmitha Duddu; Rituparna Chakrabarti; Anuran Ghosh; Praphulla Chandra Shukla
Journal:  Front Genet       Date:  2020-10-16       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.